These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1720298)

  • 1. Primary hepatocellular carcinoma in Zimbabwe: frequency of abnormal biochemical investigations.
    Marima-Matarira HT; Gudza O
    Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():512-3. PubMed ID: 1720298
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P; Fusaro A; Daziano E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical aspects of hepatocellular carcinoma in man.
    Desai HN
    S Afr Med J; 1976 Sep; 50(41):1611-3. PubMed ID: 62408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma. Evaluation of different diagnostic procedures in 13 cases, with a special note on alpha 1-fetoprotein.
    Van Waes T; Vanholder R; Van Maele V; Demeulenaere L
    Acta Clin Belg; 1976; 31(1):9-15. PubMed ID: 64099
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 10. Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.
    Terada R; Yamamoto K; Sakaguchi K; Kiyotoshi S; Yagi T; Sadamori H; Tsuji T
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1310-1. PubMed ID: 11903755
    [No Abstract]   [Full Text] [Related]  

  • 11. Assay of serum A1-antitrypsin activity for the diagnosis of primary hepato-cellular carcinoma.
    Xu SK; Guan SF; Wang PL; Chen FH; Yu EX; Xu HQ
    Chin Med J (Engl); 1983 Aug; 96(8):607-10. PubMed ID: 6196162
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
    Riener MO; Stenner F; Liewen H; Hellerbrand C; Bahra M; Kristiansen G
    Hepatology; 2009 Jul; 50(1):326. PubMed ID: 19496179
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
    Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
    J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
    Phadke AY; Desai HG
    Indian J Gastroenterol; 1996 Jul; 15(3):111. PubMed ID: 8840646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoma in childhood: report of 10 cases with emphasis on the significance of alpha--1--fetoprotein.
    Pongpipat D; Suvatte V; Talalak P; Pacharee P
    J Med Assoc Thai; 1977 Sep; 60(9):418-22. PubMed ID: 72127
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
    Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
    J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on minute hepatocellular carcinoma (author's transl)].
    Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Nagataki S; Ishii N; Koji T; Ito T; Tsuchiya R
    Nihon Shokakibyo Gakkai Zasshi; 1981 Dec; 78(12):2376-83. PubMed ID: 6176742
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum alpha-feto protein (alpha-FP) and hepatoma in Rhodesian Africans.
    Seggie J; Gelfand M
    Trans R Soc Trop Med Hyg; 1975; 69(2):209-11. PubMed ID: 52210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are alpha-fetoprotein and other markers useful in the diagnosis and prognosis of hepatocellular carcinoma?].
    Forner A; Liccioni A; Reig ME
    Gastroenterol Hepatol; 2014 Jan; 37(1):17-20. PubMed ID: 24332662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.